PuSH - Publikationsserver des Helmholtz Zentrums München

Zeitschriften-Browsing

88 Datensätze gefunden.
Zum Exportieren der Ergebnisse bitte einloggen.
Alle Publikationen dieser Seite in den Korb legen
1.
Berk, B.* et al.: 270 Impact of topical corticosteroids and pH-modulating emollients on skin physiology and skin microbiome in atopic dermatitis patients. J. Invest. Dermatol. 145, e74 - e74 (2025)
2.
Hübenthal, M.* et al.: 292 Role of innate immunity in molecular differentiation and mechanistic validation of endotypes of Atopic Dermatitis. J. Invest. Dermatol. 145, S318 - S318 (2025)
3.
Kurzen, N.* et al.: Death-associated protein kinase 1 dampens keratinocyte necroptosis and expression of genes in lichen planus. J. Invest. Dermatol. 145, 1921-1929.e13 (2025)
4.
Scala, E.* et al.: 331 IL-34 expression and function in hidradenitis suppurativa and psoriasis. In: (, 10 September 2025, Antwerp). 2025. S324 - S324 (J. Invest. Dermatol. ; 145)
5.
Schneider, M.R.* & Meier, M.: Bringing high-resolution spatial order to sebaceous glands. J. Invest. Dermatol., DOI: 10.1016/j.jid.2025.05.010 (2025)
6.
Kurzen, N.* et al.: Death associated protein kinase 1 dampens keratinocyte necroptosis and expression of inflammatory genes in lichen planus. J. Invest. Dermatol., DOI: 10.1016/j.jid.2024.11.017 (2024)
7.
Almet, A.A.* et al.: A Roadmap for a consensus human skin cell atlas and single-cell data standardization. J. Invest. Dermatol. 143, 1667-1677 (2023)
9.
Fischer, F. et al.: Gene expression-based molecular test as diagnostic aid for the differential diagnosis of psoriasis and eczema in formalin-fixed and paraffin-embedded tissue, microbiopsies, and tape strips. J. Invest. Dermatol. 143, 1461-1469.e5 (2023)
10.
Correa-Gallegos, D. ; Machens, H.G.* & Rinkevich, Y.: States and fates of skin fibroblasts revealed through chromatin accessibility. J. Invest. Dermatol. 142, 1767-1770 (2022)
11.
Rajendran, V. et al.: Therapeutic silencing of p120 in fascia fibroblasts ameliorate tissue repair. J. Invest. Dermatol. 143:854-863.e4 (2022)
12.
Seiringer, P. ; Garzorz-Stark, N.* & Eyerich, K.*: T-cell‒mediated autoimmunity: Mechanisms and future directions. J. Invest. Dermatol. 142, 804-810 (2022)
13.
Speth, P.* et al.: Immunocompromised patients with therapy-refractory chronic skin diseases show reactivation of latent EBV and CMV infection. J. Invest. Dermatol. 142, 549-558.e6 (2022)
14.
Thomas, J. et al.: CD23 levels on B cells determine long-term therapeutic response in patients with atopic eczema treated with selective IgE immune apheresis. J. Invest. Dermatol. 141, 681-685.e6 (2021)
15.
Chuah, S.Y.* et al.: Volumetric multispectral optoacoustic tomography for 3-dimensional reconstruction of skin tumors: A further evaluation with histopathologic correlation. J. Invest. Dermatol. 139, 481-485 (2019)
16.
Eyerich, K.* & Eyerich, S.: Immune response patterns in chronic inflammatory skin diseases a basis of targeted therapy. J. Invest. Dermatol. 138, S16-S16 (2018)
17.
Heppt, M.V.* et al.: MSX1-induced neural crest-like reprogramming promotes melanoma progression. J. Invest. Dermatol. 138, 141-149 (2018)
18.
Hiller, J. et al.: STAT1 gain-of-function and dominant negative STAT3 mutations impair IL-17 and IL-22 immunity associated with CMC. J. Invest. Dermatol. 138, 711-714 (2018)
19.
Jargosch, M.* et al.: Necroptosis as special type of cell death in inflammatory skin diseases. J. Invest. Dermatol. 138, S116-S116 (2018)
20.
Lauffer, F.* et al.: Type I immune response induces keratinocyte necroptosis and is associated with interface dermatitis. J. Invest. Dermatol. 138, 1785-1794 (2018)